BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 33919113)

  • 1. Hypophosphatasia: A Unique Disorder of Bone Mineralization.
    Villa-Suárez JM; García-Fontana C; Andújar-Vera F; González-Salvatierra S; de Haro-Muñoz T; Contreras-Bolívar V; García-Fontana B; Muñoz-Torres M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypophosphatasia: An overview For 2017.
    Whyte MP
    Bone; 2017 Sep; 102():15-25. PubMed ID: 28238808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa.
    Kishnani PS; Del Angel G; Zhou S; Rush ET
    Mol Genet Metab; 2021 May; 133(1):113-121. PubMed ID: 33814268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of the Perinatal Form Hypophosphatasia Caused by a Novel Large Duplication of the
    Hacıhamdioğlu B; Özgürhan G; Pereira C; Tepeli E; Acar G; Cömert S
    J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):306-310. PubMed ID: 30468149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin B
    Whyte MP; Zhang F; Mack KE; Wenkert D; Gottesman GS; Ericson KL; Cole JT; Coburn SP
    Bone; 2024 Apr; 181():117033. PubMed ID: 38307176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.
    Bowden SA; Foster BL
    Adv Exp Med Biol; 2019; 1148():279-322. PubMed ID: 31482504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypophosphatasia: Biochemical hallmarks validate the expanded pediatric clinical nosology.
    Whyte MP; Coburn SP; Ryan LM; Ericson KL; Zhang F
    Bone; 2018 May; 110():96-106. PubMed ID: 29360619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-Phenotype Associations in 72 Adults with Suspected ALPL-Associated Hypophosphatasia.
    Jandl NM; Schmidt T; Rolvien T; Stürznickel J; Chrysostomou K; von Vopelius E; Volk AE; Schinke T; Kubisch C; Amling M; Barvencik F
    Calcif Tissue Int; 2021 Mar; 108(3):288-301. PubMed ID: 33191482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue non-specific alkaline phosphatase activity and mineralization capacity of bi-allelic mutations from severe perinatal and asymptomatic hypophosphatasia phenotypes: Results from an in vitro mutagenesis model.
    Uday S; Matsumura T; Saraff V; Saito S; Orimo H; Högler W
    Bone; 2019 Oct; 127():9-16. PubMed ID: 31146036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypophosphatasia: From Diagnosis to Treatment.
    Simon S; Resch H; Klaushofer K; Roschger P; Zwerina J; Kocijan R
    Curr Rheumatol Rep; 2018 Sep; 20(11):69. PubMed ID: 30203264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges.
    Whyte MP
    J Bone Miner Res; 2017 Apr; 32(4):667-675. PubMed ID: 28084648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypophosphatasia: Canadian update on diagnosis and management.
    Khan AA; Josse R; Kannu P; Villeneuve J; Paul T; Van Uum S; Greenberg CR
    Osteoporos Int; 2019 Sep; 30(9):1713-1722. PubMed ID: 30915507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Infantile Hypophosphatasia on Human Dental Tissue.
    Wölfel EM; von Kroge S; Matthies L; Koehne T; Petz K; Beikler T; Schmid-Herrmann CU; Kahl-Nieke B; Tsiakas K; Santer R; Muschol NM; Herrmann J; Busse B; Amling M; Rolvien T; Jandl NM; Barvencik F
    Calcif Tissue Int; 2023 Mar; 112(3):308-319. PubMed ID: 36414794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.
    Whyte MP
    Nat Rev Endocrinol; 2016 Apr; 12(4):233-46. PubMed ID: 26893260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone healing and reactivation of remodeling under asfotase alfa therapy in adult patients with pediatric-onset hypophosphatasia.
    Stürznickel J; Schmidt FN; von Vopelius E; Delsmann MM; Schmidt C; Jandl NM; Oheim R; Barvencik F
    Bone; 2021 Feb; 143():115794. PubMed ID: 33301963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypophosphatasia: Vitamin B
    Whyte MP; Zhang F; Wenkert D; Mack KE; Bijanki VN; Ericson KL; Coburn SP
    Bone; 2022 Jan; 154():116204. PubMed ID: 34547524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel combination of biallelic ALPL mutations associated with adult hypophosphatasia: A phenotype-genotype association and computational analysis study.
    Martins L; de Almeida AB; Dos Santos EJL; Foster BL; Machado RA; Kantovitz KR; Coletta RD; Nociti FH
    Bone; 2019 Aug; 125():128-139. PubMed ID: 31077853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four novel mutations in the
    Xu L; Pang Q; Jiang Y; Wang O; Li M; Xing X; Xia W
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29724887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and clinical analysis of ALPL in a cohort of patients with suspicion of Hypophosphatasia.
    Tenorio J; Álvarez I; Riancho-Zarrabeitia L; Martos-Moreno GÁ; Mandrile G; de la Flor Crespo M; Sukchev M; Sherif M; Kramer I; Darnaude-Ortiz MT; Arias P; Gordo G; Dapía I; Martinez-Villanueva J; Gómez R; Iturzaeta JM; Otaify G; García-Unzueta M; Rubinacci A; Riancho JA; Aglan M; Temtamy S; Hamid MA; Argente J; Ruiz-Pérez VL; Heath KE; Lapunzina P
    Am J Med Genet A; 2017 Mar; 173(3):601-610. PubMed ID: 28127875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Efficacy of Reduced Doses of Asfotase Alfa Replacement Therapy in an Infant With Hypophosphatasia Who Lacked Severe Clinical Symptoms.
    Fujisawa Y; Kitaoka T; Ono H; Nakashima S; Ozono K; Ogata T
    Front Endocrinol (Lausanne); 2020; 11():590455. PubMed ID: 33391183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.